A Pandemic Influenza H1N1 Live Vaccine Based on Modified Vaccinia Ankara Is Highly Immunogenic and Protects Mice in Active and Passive Immunizations

Annett Hessel, Michael Schwendinger, Daniela Fritz et al. · 2010

Read A Pandemic Influenza H1N1 Live Vaccine Based on Modified Vaccinia Ankara Is Highly Immunogenic and Protects Mice in Active and Passive Immunizations by Annett Hessel, Michael Schwendinger, Daniela Fritz et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0012217.txt.

Description

Annett Hessel, Michael Schwendinger, Daniela Fritz, and co-authors built a flu vaccine on a harmless virus backbone, in PLOS ONE in 2010. Their target was the pandemic H1N1 flu that swept the world in 2009. The carrier, a weakened poxvirus, was loaded with flu parts so one shot could raise both antibody and killer-cell defenses, broader protection than standard flu shots give.

In mice the vaccine raised strong immune responses and protected animals from flu challenge. Protection even transferred with immune material from vaccinated animals to unvaccinated ones. A platform that can be reloaded for each new flu strain is exactly what pandemic planners want on the shelf.

Catalog record

CREATORAnnett Hessel, Michael Schwendinger, Daniela Fritz et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE60 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0012217

Browse the full library · About the Tower of Babel